Daunorubicin Export Market Intelligence: India's 113 Suppliers Shipping to 66 Countries — TransData Nexus 2026

Q: Who are the top daunorubicin exporters from India?

The top daunorubicin exporters from India are: 1. BIOZENTA LIFESCIENCE PRIVATE LIMITED — $87.0K (12.6% market share); 2. ZANDRA LIFE SCIENCES PRIVATE LIMITED — $81.0K (11.7% market share); 3. NAPROD LIFE SCIENCES PRIVATE LIMITED — $57.6K (8.3% market share); 4. UNITED BIOTECH PRIVATE LIMITED — $42.4K (6.1% market share); 5. 3S CORPORATION — $37.5K (5.4% market share). Together they account for 44.1% of India's total daunorubicin export value.

Q: What is the total export value of daunorubicin from India?

The total export value of daunorubicin from India is $692.3K USD, recorded across 400 shipment transactions from 113 active exporters to 66 destination countries. The average shipment value is $1.7K.

Q: Which countries import daunorubicin from India?

India exports daunorubicin to 66 countries worldwide. The top importing countries are: COLOMBIA (25.6% share, $177.0K), UZBEKISTAN (12.1% share, $84.0K), VENEZUELA (9.3% share, $64.2K), UNITED ARAB EMIRATES (8.0% share, $55.5K), SRI LANKA (7.9% share, $54.6K). These five markets account for 62.9% of total export value.

Q: What is the HS code for daunorubicin exports from India?

The primary HS code for daunorubicin exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of daunorubicin exports from India?

The average unit price for daunorubicin exports from India is $6.86 USD per unit, with prices ranging from $0.06 to $368.72 depending on formulation, packaging, and order volume. The total market is valued at $692.3K across 400 shipments.

Q: Which ports handle daunorubicin exports from India?

The primary ports for daunorubicin exports from India are SAHAR AIR CARGO ACC (INBOM4) (23.0% of shipments), SAHAR AIR (22.3% of shipments), DELHI AIR CARGO ACC (INDEL4) (12.0% of shipments), DELHI AIR (9.5% of shipments), Bombay Air (9.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of daunorubicin?

India is one of the world's leading exporters of daunorubicin due to its large base of 113 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports daunorubicin to 66 countries, demonstrating 34% global market coverage.

Q: What certifications do Indian daunorubicin exporters need?

Indian daunorubicin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import daunorubicin from India?

There are 167 registered buyers importing daunorubicin from India, spread across 66 countries. The repeat buyer rate is 41.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top daunorubicin supplier from India?

BIOZENTA LIFESCIENCE PRIVATE LIMITED is the leading daunorubicin exporter from India with a market share of 12.6% and total export value of $87.0K across 6 shipments. The top 5 suppliers together control 44.1% of total export value.

Suresh Sormare

Daunorubicin

India Pharmaceutical Trade Intelligence

$692.3K113 Suppliers66 CountriesHS 30049049

ExportsIndia → COLOMBIA25.6%India → UZBEKISTAN12.1%

ImportsBULGARIA → India$34.8K

#1 Supplier: BIOZENTA LIFESCIENCE

Daunorubicin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Daunorubicin to the World

Between 2022 and 2026, India exported $692.3K worth of daunorubicin across 400 verified shipments to 66 countries — covering 34% of world markets in the Advanced Oncology segment. The largest destination is COLOMBIA (25.6%). BIOZENTA LIFESCIENCE PRIVATE LIMITED leads with a 12.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Daunorubicin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Daunorubicin export data snapshot — $692.3K · 113 exporters · 66 countriesTransData Nexus · Indian Customs Data

Top Daunorubicin Exporters from India

113 active exporters · Ranked by export value

View all 113 →

Top Daunorubicin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BIOZENTA LIFESCIENCE PRIVATE LIMITED	$87.0K	6	2	12.6%
2	ZANDRA LIFE SCIENCES PRIVATE LIMITED

Top Countries Importing Daunorubicin from India

66 destination markets · Ranked by import value

All 66 countries →

Top Countries Importing Daunorubicin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	COLOMBIA	$177.0K	25.6%
2	UZBEKISTAN	$84.0K	12.1%
3	VENEZUELA	$64.2K	9.3%
4	UNITED ARAB EMIRATES	$55.5K	8.0%
5	SRI LANKA	$54.6K	7.9%
6	KAZAKHSTAN	$26.3K	3.8%
7	POLAND	$23.8K	3.4%
8	LEBANON	$22.0K	3.2%
9	GERMANY	$19.4K	2.8%
10	PANAMA	$15.0K	2.2%

COLOMBIA is India's largest daunorubicin export destination, absorbing 25.6% of total exports worth $177.0K. The top 5 importing countries — COLOMBIA, UZBEKISTAN, VENEZUELA, UNITED ARAB EMIRATES, SRI LANKA — together account for 62.9% of India's total daunorubicin export value. The remaining 61 destination countries collectively receive the other 37.1%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Daunorubicin to India?

1 origin countries · Total import value: $34.8K

India imports daunorubicin from 1 countries with a combined import value of $34.8K. The largest supplier is BULGARIA ($34.8K, 1 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Daunorubicin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	BULGARIA	$34.8K	1	100.0%

BULGARIA is the largest supplier of daunorubicin to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Daunorubicin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Daunorubicin, an anthracycline antibiotic used primarily in the treatment of acute myeloid leukemia (AML), has been a critical component in chemotherapy regimens. According to the FDA's Orange Book, multiple Abbreviated New Drug Applications (ANDAs) for daunorubicin have been approved, indicating a well-established generic market presence. The most recent approval was granted in June 2025, reflecting ongoing interest and investment in this therapeutic area.

Despite the presence of numerous approved ANDAs, the U.S. market for daunorubicin remains competitive. The absence of current import alerts related to daunorubicin suggests that Indian exporters are maintaining compliance with FDA standards. However, with 113 active Indian exporters and 167 buyers, the market is fragmented, necessitating stringent adherence to regulatory requirements to ensure market access and competitiveness.

2EU & UK Regulatory Framework

In the European Union, daunorubicin has been recognized for its therapeutic value in treating AML. Notably, in December 2008, the European Medicines Agency (EMA) granted orphan designation to liposomal daunorubicin for the treatment of AML, highlighting its significance in addressing this rare condition. This designation underscores the EU's commitment to facilitating the development of treatments for rare diseases.

Manufacturers exporting daunorubicin to the EU and UK must comply with Good Manufacturing Practice (GMP) standards as outlined by the EMA and the UK's Medicines and Healthcare products Regulatory Agency (MHRA). These standards ensure the quality and safety of pharmaceutical products, and adherence is mandatory for market authorization.

3WHO Essential Medicines & Global Standards

Daunorubicin is listed in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025. This inclusion signifies its critical role in treating priority health conditions globally. The WHO Model List serves as a guide for countries to develop their national essential medicines lists, promoting access to vital treatments.

Regarding pharmacopoeial standards, daunorubicin is included in major compendia such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is essential for ensuring the quality and efficacy of the drug across different markets.

4India Regulatory Classification

In India, daunorubicin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. This classification mandates that daunorubicin can only be sold with a valid prescription from a registered medical practitioner.

The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of essential medicines in India. As of March 2026, daunorubicin is subject to price control under the Drug Price Control Order (DPCO), ensuring its affordability and accessibility. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of daunorubicin, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for daunorubicin have expired, leading to a robust generic market with multiple manufacturers producing the drug. This competitive landscape has contributed to the drug's affordability and widespread availability.

6Recent Industry Developments

In June 2025, the FDA approved a new generic formulation of daunorubicin, enhancing treatment options for AML patients. This approval reflects the ongoing efforts to increase access to essential chemotherapy agents.

In September 2025, the WHO updated its Model List of Essential Medicines, reaffirming daunorubicin's inclusion and emphasizing its importance in global health. This update serves as a guideline for countries to prioritize essential medicines in their healthcare systems.

In December 2025, the EMA issued new guidelines on the manufacturing of anthracycline antibiotics, including daunorubicin, to enhance quality control measures. These guidelines aim to ensure the safety and efficacy of these critical medications.

In January 2026, the NPPA revised the ceiling price for daunorubicin under the DPCO, reflecting changes in production costs and market dynamics. This revision aims to balance affordability for patients with sustainability for manufacturers.

In February 2026, the CDSCO implemented stricter export NOC requirements for daunorubicin to ensure compliance with international quality standards. These measures are intended to maintain the reputation of Indian pharmaceutical exports in global markets.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Daunorubicin

Retail & reference prices across 9 markets vs. India FOB export price of $6.86/unit

Global Price Benchmark for Daunorubicin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$29.49 – $30.12	USD	According to the FDA Orange Book, daunorubicin is approved for intravenous use.
United Kingdom	Data not available	GBP	Daunorubicin is listed in the British National Formulary (BNF) for intravenous administration.
Germany	Data not available	EUR	Daunorubicin is approved by the European Medicines Agency (EMA) for intravenous use.
Australia	Data not available

Supply Chain Risk Assessment — Daunorubicin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Daunorubicin, an anthracycline antibiotic used in chemotherapy, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, indicating a significant concentration risk in the pharmaceutical supply chain.

Recent disruptions have highlighted the vulnerabilities associated with this reliance. In September 2020, China increased prices of key drug materials by 10-20%, impacting the cost structures of Indian pharmaceutical manufacturers. Such price hikes can discourage indigenous API production, making it less competitive against Chinese products globally.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Daunorubicin account for 44.1% of the total export value, with BIOZENTA LIFESCIENCE PRIVATE LIMITED leading at 12.6%. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global supply.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing import dependence on critical pharmaceutical ingredients. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a step towards self-reliance.

Access Complete Daunorubicin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 400 transactions across 66 markets.

Request Demo View Pricing

Frequently Asked Questions — Daunorubicin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top daunorubicin exporters from India?

The leading daunorubicin exporters from India are BIOZENTA LIFESCIENCE PRIVATE LIMITED, ZANDRA LIFE SCIENCES PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, and 7 others. BIOZENTA LIFESCIENCE PRIVATE LIMITED leads with 12.6% market share ($87.0K). The top 5 suppliers together control 44.1% of total export value.

What is the total export value of daunorubicin from India?

The total export value of daunorubicin from India is $692.3K, recorded across 400 shipments from 113 active exporters to 66 countries. The average shipment value is $1.7K.

Which countries import daunorubicin from India?

India exports daunorubicin to 66 countries. The top importing countries are COLOMBIA (25.6%), UZBEKISTAN (12.1%), VENEZUELA (9.3%), UNITED ARAB EMIRATES (8.0%), SRI LANKA (7.9%), which together account for 62.9% of total export value.

What is the HS code for daunorubicin exports from India?

The primary HS code for daunorubicin exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Daunorubicin

Daunorubicin

Top Daunorubicin Exporters from India

Top Countries Importing Daunorubicin from India

Who Supplies Daunorubicin to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Daunorubicin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Daunorubicin

Supply Chain Risk Assessment — Daunorubicin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Daunorubicin Trade Intelligence

Frequently Asked Questions — Daunorubicin Exports from India

Who are the top daunorubicin exporters from India?

What is the total export value of daunorubicin from India?

Which countries import daunorubicin from India?

What is the HS code for daunorubicin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of daunorubicin exports from India?

Which ports handle daunorubicin exports from India?

Why is India a leading exporter of daunorubicin?

What certifications do Indian daunorubicin exporters need?

How many buyers import daunorubicin from India?

What is the market share of the top daunorubicin exporter from India?

Analysis Methodology